JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

MEK1/2

A5707 PD318088

Target: MEK

Summary: Allosteric MEK1/2 inhibitor, non-ATP competitive

≥28.05 mg/mL
A5573 Pimasertib (AS-703026)

Target: MEK

Summary: MEK1/2 inhibitor

≥21.55 mg/mL
A3887 Trametinib DMSO solvate
1 Citation

Target: MEK

Summary: Allosteric MEK1/MEK2 kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥11.2 mg/mL
A3805 SCH772984
7 Citation

Summary: ERK1 and ERK2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.7 mg/mL
A3594 MEK inhibitor

Summary: Potent MEK inhibitor, Antitumor agent

Soluble in DMSO
A3323 Cobimetinib (R-enantiomer)

Summary: Selective MEK inhibitor

Soluble in DMSO
A3322 Cobimetinib (racemate)

Summary: Selective MEK inhibitor

Soluble in DMSO
A3321 Cobimetinib
3 Citation

Summary: Selective MEK inhibitor

≥26.55 mg/mL
A3018 Trametinib (GSK1120212)
7 Citation

Target: MEK

Summary: MEK1 and MEK2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
A3016 PLX-4720
1 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥20.69 mg/mL